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Editor’s Choice
Section Editor
Robert C. Griggs, MD
Editors’ Note: In reference to the article “Damping of
monocular pendular nystagmus with vibration in a patient
with multiple sclerosis,” Dr. Ehling et al. describe their
own unsuccessful attempt at vibration therapy. Authors
Zee et al. discuss their ongoing investigation into the
treatment. Dr. Burke calls for a correction to the article
“Aldehyde dehydrogenase variation enhances effect of
pesticides associated with Parkinson disease,” over the
absence of evidence of 3,4-dihydroxyphenylacetaldehyde
(DOPAL) toxicity to dopaminergic neurons in a previous
study cited by the authors. A correction has been duly
published with the appropriate attributions.
—Megan Alcauskas, MD, and Robert C. Griggs, MD
DAMPING OF MONOCULAR PENDULAR
NYSTAGMUS WITH VIBRATION IN A PATIENT
WITH MULTIPLE SCLEROSIS
Rainer Ehling, Muenster; Andreas Lutterotti,
Innsbruck; Christian Brenneis, Muenster, Austria:
Inspired by Beh et al.,1 we used the vibration tech-
nique in a 24-year-old woman with multiple sclerosis
(MS) presenting with monocular, vertical pendular
nystagmus (PN) with 4–5 Hz and oscillopsia. Cerebral
MRI revealed T2 lesions at the ponto-mesencephalic
junction on the left and in the cerebellum on the right
side. However, vibration using the Mini Vibrator
(100 Hz; Rehaforum Medical, Elmshorn, Germany)
over the vertex, both mastoids, and the chin did not
relieve oscillopsia or nystagmus. It is possible that the
vertical nature of the PN in our patient—unlike
the authors’ patient—affected different structures of
the neural integrator (NI) and was less influenced by
peripheral feedback. Therefore, the specific lesion site
of the NI in the brainstem or cerebellum might con-
tribute to different responses to vibration. In addition,
our patient’s discomfort during the procedure may
have inhibited success of this therapy. When intended
as a permanent therapy, vibration might even delay
adaptation processes in an inflammatory disease like
MS, in which remyelination and compensatory mech-
anisms are frequent in the early disease course.2
Author Response: David S. Zee, Baltimore; Shin
C. Beh, Dallas; Amir Kheradmand, Baltimore:We
thank Ehling et al. for their comments. Since our
original observation,1 we have used vibration in sev-
eral more patients with nystagmus. Some—but not
all—patients responded. Similar to other treatments
for nystagmus, not every patient responds and it may
depend on the nature or location of the lesion.
The type of vibrator may also be important and we
are currently investigating options. Our original
suggestion for treatment was for transient use,
perhaps minutes, when high visual acuity and image
stability were needed. We have no evidence that brief
periods of vibration will enhance or retard compen-
sation in demyelinating diseases but we consider it
unlikely. Further investigation is necessary to deter-
mine modulation of nystagmus with skull vibration.
© 2014 American Academy of Neurology
1. Beh SC, Tehrani AS, Kheradmand A, Zee DS. Damping of
monocular pendular nystagmus with vibration in a patient
with multiple sclerosis. Neurology 2014;82:1380–1381.
2. Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:
1502–1517.
ALDEHYDE DEHYDROGENASE VARIATION
ENHANCES EFFECT OF PESTICIDES
ASSOCIATED WITH PARKINSON DISEASE
William J. Burke, St. Louis: In their article on alde-
hyde dehydrogenase variation and effect on pesticides
associated with Parkinson disease (PD), the conclu-
sions of Fitzmaurice et al.1 are based on the findings
that 3,4-dihydroxyphenylacetaldehyde (DOPAL) is
toxic to dopamine neurons. They stated: “We previ-
ously reported that pesticide-induced ALDH inhibi-
tion can lead to the accumulation of toxic aldehydes
(e.g., DOPAL) and result in dopaminergic cell
death.11” Their reference 112 is an earlier study by
these authors. There is no direct study of DOPAL
or its toxicity in this article. The correct attributions
to DOPAL toxicity are in vitro3 and in vivo.4 A cor-
rection should be published.
Author Response: Jeff M. Bronstein, Arthur
Fitzmaurice, Los Angeles: Dr. Burke is a key inves-
tigator in this field highlighting the potential impor-
tance of DOPAL in PD pathogenesis. It was his work
and others that we referenced that led us to pursue
ALDH activity in our study of pesticides. We agree
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